Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001 — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001 — Stella

Recruiting

Back to Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy trials

Trial locations(4 sites)

France

Clinical Trial Site, Paris

New Zealand

Clinical Trial Site, Auckland

Sweden

Clinical Trial Site, Umeå

United Kingdom

Clinical Trial Site, London

Key details

Sponsor

Intellia Therapeutics

Enrollment target

~72 participants

Started

July 2023

Primary completion

March 2038

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov